Trademark Overview
On Tuesday, December 31, 2024, a trademark application was filed for NANOIMMUNOCEL with the United States Patent and Trademark Office. The USPTO has given the NANOIMMUNOCEL trademark a serial number of 98931142. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 16, 2025. This trademark is owned by NANOIMMUNOCEL Inc. The NANOIMMUNOCEL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Antibodies for medical purposes; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer immunotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
Pharmaceutical research and development; Providing information about medical and scientific research via a website; Providing medical and scientific research information; Providing medical research and scientific research information in the field of oncology via the Internet; Consulting services in the field of pharmaceutical research and development; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer